$AMRN “Amarin is an Ireland-based biotech firm that recently received FDA approval for a new drug to treat cardiovascular disease. Healey says that Amarin stock also has strong institutional support from the Baker Brothers health care hedge fund and that he's added positions in Amarin stock to his client portfolios. "It can really stand to be a blockbuster drug," Healey said. "It can be a potential takeover candidate." https://www.investors.com/how-to-invest/stock-market-correction-due-now-advisor-says-needed/
  • 3
  • 4